But an association with improved overall survival failed to reach statistical significance ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had ...

During the early years of the COVID-19 pandemic, experts worried that disruptions to cancer diagnosis and treatment would ...

Regarding site-specific survival, the authors broke down diagnoses into low-survival cancer sites or ...

CHICAGO -- A cheap, decades-old chemotherapy drug extended life by more than a year when added to standard hormone therapy for men whose prostate cancer has widely spread, doctors reported Sunday. Men ...

Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.

A separate 2024 study in the Journal of the National Cancer Institute documented a dip in one-year survival for patients ...

A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.